Malignant neoplasm of long bones of unspecified lower limb
- C40.20 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C40.20 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C40.20 – other international versions of ICD-10 C40.20 may differ.
The following code(s) above C40.20 contain annotation back-references
that may be applicable to C40.20:
- C00-D49 Neoplasms
- C40-C41 Malignant neoplasms of bone and articular cartilage
- C40 Malignant neoplasm of bone and articular cartilage of limbs
Approximate Synonyms
- Adamantinoma of long bone of lower limb
- Cancer of the bone, long bone of lower limb
- Cancer of the bone, lower limb
- Cancer of the bone, lower limb, chondrosarcoma
- Cancer of the bone, lower limb, osteosarcoma
- Cancer of the leg bones, adamantioma
- Osteosarcoma of lower limb
- Primary chondrosarcoma of bone of lower limb
- Primary malignant neoplasm of bone of lower limb
- Primary malignant neoplasm of long bone of lower limb
ICD-10-CM C40.20 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 542 Pathological fractures and musculoskeletal and connective tissue malignancy with mcc
- 543 Pathological fractures and musculoskeletal and connective tissue malignancy with cc
- 544 Pathological fractures and musculoskeletal and connective tissue malignancy without cc/mcc
Convert C40.20 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change